Adam Logal
Director of Finance/CFO at OPKO HEALTH, INC.
Net worth: 214 997 $ as of 2024-03-30
Profile
Mr. Adam E.
Logal is a Chairman at Xenetic Biosciences, Inc. and a CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. He is on the Board of Directors at Bio-Reference Laboratories, Inc. and OPKO Biologics Ltd.
Mr. Logal was previously employed as an Independent Director by VBI Vaccines, Inc., a Finance Director, Secretary, Treasurer & CAO by eXegenics, Inc., and a Chief Financial & Accounting Officer by Nabi Biopharmaceuticals.
He also served on the board at SciVac Therapeutics, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
OPKO HEALTH, INC.
0.03% | 2024-02-28 | 179,164 ( 0.03% ) | 214 997 $ | 2024-03-30 |
2023-12-05 | 0 ( -.--% ) | - $ | 2024-03-30 |
Adam Logal active positions
Companies | Position | Start |
---|---|---|
OPKO HEALTH, INC. | Director of Finance/CFO | 2014-03-30 |
BIO-REFERENCE LABORATORIES INC | Director/Board Member | 2015-08-19 |
XENETIC BIOSCIENCES, INC. | Chairman | 2017-08-13 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Director/Board Member | 2014-03-31 |
Former positions of Adam Logal
Companies | Position | End |
---|---|---|
VBI VACCINES INC. | Director/Board Member | 2018-09-30 |
eXegenics, Inc. | Director of Finance/CFO | 2007-06-12 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Director of Finance/CFO | 2006-12-31 |
SciVac Therapeutics, Inc. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
OPKO HEALTH, INC. | Health Services |
VBI VACCINES INC. | Health Technology |
Private companies | 6 |
---|---|
Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
eXegenics, Inc. | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
Xenetic Biosciences, Inc. | |
SciVac Therapeutics, Inc. | Health Technology |
- Stock Market
- Insiders
- Adam Logal